Rhea-AI Summary
Mizuho Financial Group, Inc. has filed Amendment No. 3 to its Schedule 13G stating that it now beneficially owns 0 common shares of Aimei Health Technology Co., Ltd., representing 0.0% of the common share class as of 12/31/2025.
The filing reports no sole or shared voting or dispositive power over Aimei’s common shares. Mizuho is identified as a parent holding company, and notes that related entities may have been indirect beneficial owners through a wholly owned subsidiary, Mizuho Securities USA LLC.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
How many Aimei Health Technology Co., Ltd. (AFJKR) SEC filings are available on StockTitan?
StockTitan tracks 21 SEC filings for Aimei Health Technology Co., Ltd. (AFJKR), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.
When was the most recent SEC filing for Aimei Health Technology Co., Ltd. (AFJKR)?
The most recent SEC filing for Aimei Health Technology Co., Ltd. (AFJKR) was filed on February 12, 2026.